Published in Drug Week, November 15th, 2002
A statement from AstraZeneca, maker of Seroquel, said a low percentage of patients in the study who were on Seroquel required treatment for type 2 diabetes.
Claims data within a health plan from nearly 17,000 patients with psychosis were analyzed using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.